Market Research Logo

Acute Myeloid Leukemia Pipeline Highlights – 2017 Update

Acute Myeloid Leukemia Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Acute Myeloid Leukemia Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Acute Myeloid Leukemia market. It covers emerging therapies for Acute Myeloid Leukemia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Acute Myeloid Leukemia pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Acute Myeloid Leukemia pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Acute Myeloid Leukemia pipeline products by the company.

Short-term Launch Highlights:
Find out which Acute Myeloid Leukemia pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

  • Acute Myeloid Leukemia phase 3 clinical trial pipeline products
  • Acute Myeloid Leukemia phase 2 clinical trial pipeline products
  • Acute Myeloid Leukemia phase 1 clinical trial pipeline products
  • Acute Myeloid Leukemia preclinical research pipeline products
  • Acute Myeloid Leukemia discovery stage pipeline products
  • Acute Myeloid Leukemia pipeline products short-term launch highlights


1. Acute Myeloid Leukemia Pipeline by Stages
2. Acute Myeloid Leukemia Pipeline by Drug Class
3. Acute Myeloid Leukemia Pipeline by Company
4. Acute Myeloid Leukemia Phase 3 Clinical Trial Insights
5. Acute Myeloid Leukemia Phase 2 Clinical Trial Insights
6. Acute Myeloid Leukemia Phase 1 Clinical Trial Insights
7. Acute Myeloid Leukemia Preclinical Research Insights
8. Acute Myeloid Leukemia Discovery Stage Insights
9. Appendix
10. Research Methodology
LIST OF TABLES
Table 1: Acute Myeloid Leukemia Phase 3 Clinical Trials, 2017
Table 2: Acute Myeloid Leukemia Phase 2 Clinical Trials, 2017
Table 3: Acute Myeloid Leukemia Phase 1 Clinical Trials, 2017
Table 4: Acute Myeloid Leukemia Preclinical Research, 2017
Table 5: Acute Myeloid Leukemia Discovery Stage, 2017
LIST OF FIGURES
Figure 1: Acute Myeloid Leukemia Pipeline Molecules by Clinical Trials Stage, 2017
Figure 2: Acute Myeloid Leukemia Pipeline Molecules by Drug Class, 2017
Figure 3: Acute Myeloid Leukemia Pipeline Molecules by Company, 2017
Figure 4: Acute Myeloid Leukemia Phase 3 Clinical Trial Highlights, 2017
Figure 5: Acute Myeloid Leukemia Phase 2 Clinical Trial Highlights, 2017
Figure 6: Acute Myeloid Leukemia Phase 1 Clinical Trial Highlights, 2017
Figure 7: Acute Myeloid Leukemia Preclinical Research Highlights, 2017
Figure 8: Acute Myeloid Leukemia Discovery Stage Highlights, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report